Minomi K. Subapanditha

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target.

uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target.

Journal: Science translational medicine

Published: May 13, 2026

Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for Glioblastoma.

Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for Glioblastoma.

Journal: International journal of cancer

Published: August 05, 2025

Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cells.

Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cells.

Journal: Nature

Published: December 09, 2024

De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases.

De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases.

Journal: Cell reports. Medicine

Published: December 11, 2023

Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells.

Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells.

Journal: Nature medicine

Published: August 03, 2023

An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma.

An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma.

Journal: Journal of neuro-oncology

Published: May 06, 2023

Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.

Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.

Journal: Nature communications

Published: January 10, 2023

Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors.

Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors.

Journal: Frontiers in immunology

Published: March 27, 2022

Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma.

Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma.

Journal: Cell reports

Published: January 14, 2022

Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.

Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.

Journal: Science advances

Published: December 08, 2021

CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.

CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.

Journal: Journal for immunotherapy of cancer

Published: October 25, 2021

Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.

Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.

Journal: Nature communications

Published: May 21, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026